Skip to main navigation Skip to search Skip to main content

An orally available immunomodulatory polysaccharide compound for Alzheimer's disease therapy.

Project: Research

Project Details

StatusFinished
Effective start/end date1/04/2230/03/25

Collaborative partners

Funding

  • Invest Northern Ireland: £145,203.69